Cargando…
Defining and targeting health disparities in chronic obstructive pulmonary disease
The global burden of chronic obstructive pulmonary disease (COPD) continues to grow in part due to better outcomes in other major diseases and in part because a substantial portion of the worldwide population continues to be exposed to inhalant toxins. However, a disproportionate burden of COPD occu...
Autores principales: | Pleasants, Roy A, Riley, Isaretta L, Mannino, David M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065167/ https://www.ncbi.nlm.nih.gov/pubmed/27785005 http://dx.doi.org/10.2147/COPD.S79077 |
Ejemplares similares
-
Health-related quality of life and chronic obstructive pulmonary disease in North Carolina
por: Brown, David W., et al.
Publicado: (2010) -
Is It Time to Abandon the Postbronchodilator Requirement in Defining Chronic Obstructive Pulmonary Disease?
por: Mannino, David M.
Publicado: (2022) -
Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease
por: Pleasants, Roy A.
Publicado: (2018) -
Update on the management of chronic obstructive pulmonary disease
por: Maas, Andrea K, et al.
Publicado: (2010) -
Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective
por: Chen, Ken, et al.
Publicado: (2020)